Labial Puff is a common consumer term for non-surgical labia majora volume restoration. In most clinic settings, it refers to hyaluronic acid filler placed in the outer labia majora to support volume, contour and selected comfort concerns.

Yes, in practical search terms they usually refer to the same treatment. Labial Puff is the consumer-facing name, while labia majora filler or labia majora volume restoration is the more anatomically precise description.

Not exactly. Many people search for vaginal filler online, but Labial Puff is usually an external vulval treatment involving the labia majora. It is not the same as an internal vaginal wall injection or vaginal tightening treatment.

The treatment is usually placed in the labia majora, the outer folds of the vulva. The exact area and approach are confirmed only after consultation and assessment.

Some women enquire because of labia majora volume loss, asymmetry, external tissue deflation, friction, clothing discomfort or changes after menopause, childbirth, ageing or weight change. Suitability is assessed individually.

It may be discussed where menopause has contributed to external labia majora volume loss or tissue change. However, it is not a cure for GSM and does not replace appropriate menopause care, vaginal moisturisers, lubricants or vaginal oestrogen where these are suitable.

Some women enquire after childbirth where the external tissue looks or feels different. Postpartum symptoms can also involve pelvic floor change, scarring, hormonal changes or pain conditions, so assessment is important before any procedure is considered.

Some women notice external volume loss after significant weight change. Labial Puff may be discussed where the concern is labia majora deflation, but results and suitability vary.

Local comfort measures may be used. Some women feel pressure, stinging or tenderness. It should not be described as painless, and temporary sensitivity after treatment can occur.

Treatment time varies by assessment, product, technique and anatomy. Many filler appointments are relatively short, but the consultation and suitability decision are the most important parts of the pathway.

The amount of filler varies between women and depends on anatomy, starting volume, symmetry, product choice and clinical judgement. WHC should not quote a fixed amount without assessment.

Longevity varies by product, metabolism, tissue movement, anatomy and the amount used. Hyaluronic acid filler is temporary and maintenance may be discussed if treatment is suitable and beneficial.

Temporary swelling, bruising, tenderness, pressure sensitivity or asymmetry can occur. You may be advised to avoid sex, tampons, swimming, saunas, cycling, horse riding, heavy exercise or friction for a short period.

Common effects include swelling, bruising, redness and tenderness. Less common risks include infection, lumps, migration, inflammatory reaction, hypersensitivity and incomplete improvement. Rare but serious filler complications can occur, which is why clinical governance matters.

Treatment may not be suitable during pregnancy or breastfeeding, with active infection, active vulval inflammation, unexplained bleeding, undiagnosed pain, suspicious skin changes, certain autoimmune conditions, product allergy or unrealistic expectations.

No. Labiaplasty is surgery that removes or reshapes tissue, most commonly the labia minora. Labial Puff adds temporary volume to the labia majora using filler. The two treatments address different concerns.

No. Some clinics offer fat transfer to the labia majora, but this is a different pathway involving fat harvesting, processing and transfer. Labial Puff usually refers to hyaluronic acid filler placed into the external labia majora. The two approaches have different planning, recovery, risks and longevity.

Some clinics use product names such as Desirial Plus or Neauvia Rose when discussing labia majora filler. WHC should only name a product publicly once the product, indication, supply, training and internal protocol have been confirmed. Your clinician can explain the product choice at consultation.

Labial Puff is a hyaluronic acid filler treatment for external labia majora volume. O-Shot-style treatment uses platelet-rich plasma and is a different regenerative approach, usually discussed for different tissue targets and goals.

G-Shot-style treatment targets the anterior vaginal wall and is a different and more controversial intimate filler concept. Labial Puff targets the external labia majora.

Polynucleotides are regenerative or biostimulatory treatments discussed for tissue quality. Labial Puff is primarily a volume-restoration filler treatment. They may be discussed separately or as part of a wider plan if clinically appropriate.

A doctor face-to-face consultation is advised at £150. Treatment fees depend on the amount of product required, product choice and clinical plan. Please check the pricing page for the latest published fees.

Sometimes, but not automatically. Some women may be better suited to menopause care, vaginal rejuvenation, O-Shot, G-Shot, polynucleotides, exosomes, pelvic floor support or no procedure. Combination treatment should be clinician-led, not package-led.

There is some direct and product-specific evidence for hyaluronic acid filler in labia majora volume restoration, but much of it is small, uncontrolled, product-specific or based on patient-reported outcomes. WHC should explain both the promise and the limitations clearly.